Bethany Sensenig is CenExel’s Chief Financial Officer and Head of Strategy. Bethany is an accomplished biopharmaceutical executive with extensive leadership experience across finance, corporate strategy, and operations. She has held senior leadership roles in both commercial-stage and clinical-stage organizations, driving growth, strengthening financial performance, and advancing strategic initiatives.

Most recently, Bethany served as Chief Financial Officer and Head of Operations at Radius Health, where she played a key role in scaling the private equity-backed business and supporting commercial and financial growth. She previously served as Chief Financial Officer and Interim Chief Executive Officer at 9 Meters Biopharma, and as Chief Financial Officer and Head of U.S. Operations at Minovia Therapeutics, where she led business strategy and financing efforts.

Earlier in her career, Bethany spent more than a decade at Biogen, rising to Vice President of Finance and Commercial Operations with global P&L responsibility exceeding $1 billion across the U.S. and multiple international regions.

Bethany brings deep expertise in capital markets, M&A transactions, and commercial and operational leadership. She currently serves on the boards of Supernus Pharmaceuticals and Alpha Cognition.